Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Proceedings of the National Academy of Sciences of the United States of America - Tập 99 Số 18 - Trang 11854-11859 - 2002
Guangping Gao1, Mauricio R. Alvira1, Lili Wang1, Roberto Calcedo1, Julie Johnston1, James M. Wilson1
1Institute for Human Gene Therapy and Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104; and Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104

Tóm tắt

Tissues from rhesus monkeys were screened by PCR for the presence of sequences homologous to known adeno-associated virus (AAV) serotypes 1–6. DNA spanning entire rep-cap ORFs from two novel AAVs, called AAV7 and AAV8, were isolated. Sequence comparisons among these and previously described AAVs revealed the greatest divergence in capsid proteins. AAV7 and AAV8 were not neutralized by heterologous antisera raised to the other serotypes. Neutralizing antibodies to AAV7 and AAV8 were rare in human serum and, when present, were low in activity. Vectors formed with capsids from AAV7 and AAV8 were generated by using rep and inverted terminal repeats (ITRs) from AAV2 and were compared with similarly constructed vectors made from capsids of AAV1, AAV2, and AAV5. Murine models of skeletal muscle and liver-directed gene transfer were used to evaluate relative vector performance. AAV7 vectors demonstrated efficiencies of transgene expression in skeletal muscle equivalent to that observed with AAV1, the most efficient known serotype for this application. In liver, transgene expression was 10- to 100-fold higher with AAV8 than observed with other serotypes. This improved efficiency correlated with increased persistence of vector DNA and higher number of transduced hepatocytes. The efficiency of AAV8 vector for liver-directed gene transfer of factor IX was not impacted by preimmunization with the other AAV serotypes. Vectors based on these novel, nonhuman primate AAVs should be considered for human gene therapy because of low reactivity to antibodies directed to human AAVs and because gene transfer efficiency in muscle was similar to that obtained with the best known serotype, whereas, in liver, gene transfer was substantially higher than previously described.

Từ khóa


Tài liệu tham khảo

N Muzyczka, K I Berns Fields Virology, eds D M Knipe, P M Howley (Lippincott Williams & Wilkins, Philadelphia) 2, 2327–2359 (2001).

10.1126/science.149.3685.754

10.1128/jb.90.1.271-274.1965

10.1073/pnas.55.6.1467

10.1016/0042-6822(84)90271-X

10.1016/0042-6822(84)90272-1

10.1128/JVI.72.1.309-319.1998

10.1128/JVI.73.2.939-947.1999

10.1128/JVI.73.5.3994-4003.1999

10.1128/iai.2.6.716-722.1970

N R Blacklow, M D Hoggan, W P Rowe J Natl Cancer Inst 40, 319–327 (1968).

10.1038/2151186a0

D W Boucher, W P Parks, J L Melnick J Immunol 104, 555–559 (1970).

10.1016/0092-8674(83)90342-2

10.1016/S0958-1669(98)80031-1

10.1128/JVI.72.5.4212-4223.1998

10.1128/JVI.73.7.5438-5447.1999

10.1128/JVI.72.11.8568-8577.1998

10.1006/mthe.2001.0278

10.1128/JVI.73.7.6085-6088.1999

10.1128/jvi.76.5.2043-2053.2002

10.1093/hmg/10.26.3075

10.1073/pnas.97.7.3428

10.1128/JVI.74.8.3852-3858.2000

10.1006/mthe.2001.0330

10.1128/JVI.75.13.6199-6203.2001

10.1089/104303400750001390

10.1128/jvi.70.12.8934-8943.1996

10.1006/mthe.2000.0204

10.1073/pnas.94.21.11563

10.1006/mthe.2001.0329

10.1006/mthe.2001.0449

10.1006/mthe.2000.0219

10.1128/JVI.75.23.11603-11613.2001

10.1099/0022-1317-83-1-151

10.1128/JVI.76.6.2667-2675.2002

10.1038/sj.gt.3300994

Thông tin
Thông tin xuất bản

Proceedings of the National Academy of Sciences of the United States of America

Tập 99 Số 18

11854-11859

Thông tin tác giả